Suppression of glutamatergic synaptic transmission may be associated with the reduced excitability of GLP-1R activation (Ong et al., 2017)
What is the list price for Saxenda and will it impact me
Heerspink HJL, Sattar N, Pavo I et al (2022) Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
however, the presence of antibodies, and/or the magnitude of the antibody titer, were not associated with an individual patients magnitude of glycemic improvement, nor was there an association with incidence of adverse events.[123][124][125] In a phase 3 non-inferiority study, conducted in patients with type 2 diabetes inadequately controlled with metformin or sulfonylureas, comparing exenatide with basal insulin (insulin glargine), similar reductions in A1C were observed with exenatide (-1.0%) and insulin glargine(-1.1%)
Phytomedicine 87, 153575
Drawbacks exist within this class of weight loss drugs: patients can face unpleasant digestive tract symptoms, they must contend with administering their doses via subcutaneous injections, and these treatments come with hefty price tagsall factors which could influence how well patients stick with them over time and ultimately affect their overall contentment and success rates on such regimens